LAB
Standard Biotools Inc
0.722$
-5.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.0% | +1.8% | -6.3% | +3.5% | +12.1% | -9.0% | +4.7% | +9.6% | +11.6% | -6.8% | -6.4% | -6.0% | +22.4% | -14.9% | -5.6% | +53.0% | +11.9% | -26.5% | -5.4% | -8.1% | +34.2% | -30.7% | -29.2% | +36.6% | +5.4% | -7.0% | +10.1% | -8.3% | +11.1% | +61.6% | -50.6% | +99.9% | +3.9% | -56.7% | +7.6% | -10.2% | +21.7% | -11.1% | -4.9% | – | |
| – | +9.1% | +6.5% | -0.1% | +5.0% | +7.1% | -12.2% | +8.6% | +2.3% | +2.8% | -2.9% | -2.2% | -2.9% | +16.8% | -23.3% | -4.0% | +35.7% | +26.5% | -25.2% | +6.1% | +1.6% | +21.5% | -20.8% | +0.6% | +14.5% | -3.5% | -19.0% | +9.5% | +1.1% | +4.3% | +44.0% | -43.2% | +79.1% | +14.3% | -63.0% | +21.4% | -9.6% | +34.6% | -27.4% | -2.7% | – | |
| – | +16.4% | -2.0% | -11.9% | +2.0% | +17.3% | -6.0% | +1.2% | +16.4% | +18.9% | -9.7% | -9.6% | -8.6% | +27.4% | -8.0% | -6.8% | +65.1% | +3.5% | -27.4% | -13.8% | -16.8% | +48.1% | -39.5% | -63.8% | +108.3% | +21.1% | +10.0% | +10.8% | -18.0% | +19.8% | +81.1% | -57.1% | +124.2% | -5.8% | -49.6% | -3.8% | -10.8% | +8.0% | +10.4% | -6.8% | – | |
| – | -5.2% | -2.8% | -12.5% | +3.0% | -6.8% | +1.4% | +1.8% | +0.6% | +7.1% | +5.2% | -6.1% | -9.4% | +16.2% | +5.1% | -2.9% | -3.8% | +37.6% | -3.9% | -12.2% | -2.5% | -7.3% | +3.8% | +42.2% | -32.7% | -1.3% | -23.3% | -3.8% | +3.0% | +8.5% | +131.3% | -54.7% | +81.6% | +6.8% | -61.3% | +14.4% | +2.2% | +22.5% | -72.8% | -6.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -12.2% | -0.7% | -4.6% | +34.5% | -1.6% | -2.6% | -19.2% | -6.7% | +1.3% | -1.4% | -4.2% | +119.8% | -19.7% | -8.7% | +9.3% | +3.0% | -27.4% | -5.4% | -4.7% | -26.6% | -11.9% | – | |
| – | +3.8% | -1.4% | -8.6% | -2.3% | -17.1% | +13.2% | +1.2% | +4.1% | +9.0% | +4.2% | -3.8% | -7.2% | -2.8% | +16.0% | -7.4% | +5.9% | +40.1% | -11.0% | -12.2% | -1.2% | -5.3% | +26.2% | +8.2% | -11.0% | -15.6% | -10.5% | +7.5% | +4.1% | +7.5% | +142.8% | -51.8% | +35.3% | -0.5% | -35.6% | -2.7% | -4.0% | -2.4% | -35.6% | +73.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | -0.3% | +0.1% | +0.0% | +0.1% | +29.6% | +107.3% | +2.6% | +1.2% | -33.6% | -81.8% | -9.6% | +44.8% | +40.0% | -0.3% | -1.3% | +0.6% | -0.3% | +1.0% | +8.0% | +10.7% | -3.9% | +3.1% | -1.2% | +13.4% | -6.1% | +1.1% | +8.3% | -10.2% | -5.9% | -16.9% | – | – | -99.9% | +350.0% | +11.1% | -50.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -1,597.5% | – | – | – | – | -2,821.4% | – | – | -292.1% | – | – | – | -269.3% | – | – | – | – | – | – | – | +275.7% | +14.4% | -83.4% | -424.0% | – | -69.5% | +202.6% | +130.5% | -143.8% | – | – | – | – | +718.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -334.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.